-+ 0.00%
-+ 0.00%
-+ 0.00%

First patient dosed in Phase 1b study into obese subjects

ASX·11/21/2024 21:45:24

The content of this announcement was automatically generated by machine and is for reference only. The original announcement can be viewed by clicking on the link below.